Active

2022 Sanofi Golden Ticket Competition for life science and biotech

Deadline: February 11, 2022

Sanofi is now accepting submissions for the 2022 Sanofi Golden Ticket Competition!

Sanofi is a global sponsor of BioLabs, a premier shared laboratory space for life science and biotech startups to test new ideas and innovate.  Sanofi is sponsoring an inaugural global Golden Ticket Competition that will award three promising startup companies a one-year pre-paid residence at one of the respective sponsored BioLabs sites:

The two key focus areas for 2022 addressing therapeutic challenges in oncology, immuno-inflammation, neuroscience, rare diseases & vaccine are: 

  • Targeted or controlled delivery and conditional activation of biologics or genomic medicines to increase tissue specific exposure
  • New and next generation genome editing technologies with breakthrough potential for in vivo therapeutics 

All companies, based in Europe and United States, and engaged in these fields are encouraged to apply.  

Deadline to apply for the Sanofi Golden Ticket is February 11, 2022.

Applicants must submit a completed application and a non-confidential pitch deck to GoldenTicket@sanofi.com before 11:59 PM EST on February 11, 2022 to remain eligible, and submit here and we'll help you get status on your application.

A sub-set of applicants will be selected as finalists, and will be invited to present at the virtual Sanofi Golden Ticket Pitch Showcase on March 31, 2022.

More information can be found on the Sanofi site.

Deadline: February 11, 2022
Posted on: January 14, 2022
Location: Boston, Paris, or Heidelberg

Sanofi is now accepting submissions for the 2022 Sanofi Golden Ticket Competition!

Sanofi is a global sponsor of BioLabs, a premier shared laboratory space for life science and biotech startups to test new ideas and innovate.  Sanofi is sponsoring an inaugural global Golden Ticket Competition that will award three promising startup companies a one-year pre-paid residence at one of the respective sponsored BioLabs sites:

The two key focus areas for 2022 addressing therapeutic challenges in oncology, immuno-inflammation, neuroscience, rare diseases & vaccine are: 

  • Targeted or controlled delivery and conditional activation of biologics or genomic medicines to increase tissue specific exposure
  • New and next generation genome editing technologies with breakthrough potential for in vivo therapeutics 

All companies, based in Europe and United States, and engaged in these fields are encouraged to apply.  

Deadline to apply for the Sanofi Golden Ticket is February 11, 2022.

Applicants must submit a completed application and a non-confidential pitch deck to GoldenTicket@sanofi.com before 11:59 PM EST on February 11, 2022 to remain eligible, and submit here and we'll help you get status on your application.

A sub-set of applicants will be selected as finalists, and will be invited to present at the virtual Sanofi Golden Ticket Pitch Showcase on March 31, 2022.

More information can be found on the Sanofi site.


Disclaimer:  MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.